Update: Market Chatter: EQT, KKR Show Interest in PolyPeptide Takeover

(Updates with KKR's response to a request for comment.)EQT AB and KKR (KKR) are among private equity firms showing takeover interest in PolyPeptide Group, Bloomberg reported Friday, citing people with knowledge of the matter.Advent has also been reviewing a possible acquisition of the Swiss contract drugmaker, the report said.KKR declined to comment, while EQT didn't immediately reply to a request for comment from.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $90.17, Change: $-2.66, Percent Change: -2.87%

-- (Updates with KKR's response to a request for comment.)

EQT AB and KKR (KKR) are among private equity firms showing takeover interest in PolyPeptide Group, Bloomberg reported Friday, citing people with knowledge of the matter.

Advent has also been reviewing a possible acquisition of the Swiss contract drugmaker, the report said.

KKR declined to comment, while EQT didn't immediately reply to a request for comment from.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: $90.17, Change: $-2.66, Percent Change: -2.87%